Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • EU invests 30m to fight antimicrobial resistance
  • Policy / Pricing

EU invests 30m to fight antimicrobial resistance

Pharmaphorum

The EU has pledged 30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

Policy / PricingInfectious DiseaseRead full story

pharminent April 8, 2026 (Last updated: April 8, 2026)

Pharmaphorum

The EU has pledged 30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

Policy / PricingInfectious DiseaseRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: RoosterBio and MineBio team up to expand MSC solutions access in China
Next: List Price Reductions Will Deflate the Gross-to-Net Bubble-and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun)

Related Stories

  • Policy / Pricing

US launches probe of German ‘underpayment’ for medicines

pharminent June 19, 2026
  • Policy / Pricing

FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’

pharminent June 19, 2026
  • Policy / Pricing

German said to be backtracking on pharma rebate changes

pharminent June 16, 2026

You May Have Missed

  • News

pharminent June 22, 2026
sample_feature_2026-06-22
  • News

AbbVie to Acquire Apogee Therapeutics for Nearly $11 Billion in Immunology Bet

pharminent June 22, 2026
  • M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

pharminent June 22, 2026
  • M&A / Deals

Lilly bets up to $800M for BioArctic’s brain delivery tech

pharminent June 22, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.